Описание
Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.
Figure 20
Source Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 20: Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication." /> <figcaption>Figure 20. Extended analysis tables from the synbiotic IBS-D trial are presented as supplementary data from the peer review publication.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Связанные доказательства
B
Bifidobacterium longum для Irritable Bowel Syndrome (IBS)
B
Оценка B · 4 исследований
Galactooligosaccharides (GOS) для Irritable Bowel Syndrome (IBS)
B
Оценка B · 3 исследований
Lactobacillus acidophilus для Irritable Bowel Syndrome (IBS)
D
Оценка B · 3 исследований
Fructooligosaccharides (FOS) для Irritable Bowel Syndrome (IBS)
Оценка D · 2 исследований